Structure and Function of Clostridium difficile Type IV Pili
艰难梭菌 IV 型菌毛的结构和功能
基本信息
- 批准号:8964278
- 负责人:
- 金额:$ 54.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-18 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdherenceAdhesionsAlcoholsAntibodiesArchitectureBacillus (bacterium)BacteriaBindingBiogenesisBiologyCell AdhesionCellsCessation of lifeClostridiumClostridium difficileColitisCryoelectron MicroscopyDeuteriumDevelopmentDiarrheaDiseaseEvolutionFimbriae ProteinsFutureGenesGenomeGram-Negative BacteriaGram-Positive BacteriaHandHealth Care CostsHealthcareHeatingHela CellsHomoHorizontal Gene TransferHumanHydrogenImmuneImmune responseIncidenceIndividualInfectionKnowledgeLabelLeadMacromolecular ComplexesMapsMass Spectrum AnalysisMeasuresMediatingMethodsMicrobial BiofilmsNMR SpectroscopyNosocomial InfectionsPhysiologicalPilumPlayPolysaccharidesPrevention approachProkaryotic CellsProteinsPseudomembranous ColitisReceptor CellRefractoryRelapseReproduction sporesResearch PersonnelResistanceResolutionRoentgen RaysRoleSeveritiesSignal PathwayStructureSurfaceSurface Plasmon ResonanceTechniquesTherapeuticToxic MegacolonToxic effectToxinTransplantationVaccinesVirulenceX-Ray Crystallographyantimicrobialappendagebasecell motilitydesigneffective therapygastrointestinalinsightkillingsmacromoleculemacrophagemembermortalitynovelnovel strategiespathogenprotein protein interactionprotein structurepublic health relevancereceptorresearch studyresponsesuccess
项目摘要
DESCRIPTION (provided by applicant): Clostridium difficile is a spore-forming anaerobic Gram-positive bacillus that causes gastrointestinal illnesses in humans ranging from mild diarrhea to pseudomembranous colitis, which in severe cases can lead to toxic megacolon, an acute and sometimes lethal form of colonic distension. The incidence, severity and mortality of C. difficile colitis have increased significantly over the last two decades. However, knowledge concerning interactions between C. difficile bacteria and the human host is virtually nonexistent, severely impeding the development of new approaches to the prevention, control, and treatment of C. difficile disease. Type IV pili are fimbrial surface appendages produced by many bacteria that play critical roles in cellular adhesion, colonization, twitching motility, biofilm formation,and horizontal gene transfer. They are often essential for virulence and some have been successfully developed as vaccines. Type IV pili have been characterized extensively in Gram-negative bacteria, but nearly nothing is known about these pili from Gram-positive bacteria. Type IV pilin genes, though, are present in the genomes of all members of the genus Clostridium and all C. difficile strains encode complete sets of T4P biogenesis machinery components and a variable number of Type IV pilin proteins. We hypothesize that C. difficile Type IV pili, through structural features distinct from those of Gram-negative Type IV pili, directy mediate human cell adherence that is important for both colonization and virulence. Accordingly, we seek to define C. difficile Type IV pilin structures, both as individual protein components and assembled supramolecular appendages, and to identify their human host cell receptors, by pursuing the following Specific Aims: (1) to determine the atomic structures of individual C. difficile Type IV pilin proteins; (2) to define the composition and architecture of C. difficile Tye IV pili; and (3) to identify host molecules engaged specifically by C. difficile Type IV pili. The comprehensive approach that we propose to investigate the structure and function of C. difficile Type IV pili will utilize protein structure determination methods throughout a broad range of resolutions, including X-ray crystallography, NMR spectroscopy, small-angle X-ray scattering and cryo-electron microscopy, as well as state-of-the-art mass spectrometry-based approaches to define the composition of multi-component protein assemblies, map protein-protein interfaces and identify novel receptor molecules. To assure the success of our proposed studies, we have assembled a team of outstanding investigators with extensive expertise in these experimental techniques, C. difficile biology and Type IV pilus structure and function.
描述(由申请人提供):艰难梭菌是一种形成孢子的厌氧革兰氏阳性杆菌,可引起人类胃肠道疾病,从轻度腹泻到伪膜性结肠炎,在严重的情况下可导致中毒性巨结肠,这是一种急性且有时致命的结肠扩张形式。过去二十年来,艰难梭菌结肠炎的发病率、严重程度和死亡率显着增加。然而,关于艰难梭菌细菌与人类宿主之间相互作用的知识实际上是不存在的,这严重阻碍了预防、控制和治疗艰难梭菌疾病的新方法的开发。 IV 型菌毛是由许多细菌产生的菌毛表面附属物,在细胞粘附、定植、抽搐运动、生物膜形成和水平基因转移中发挥关键作用。它们通常对于毒力至关重要,有些已成功开发为疫苗。 IV 型菌毛已在革兰氏阴性菌中得到广泛表征,但对革兰氏阳性菌中的这些菌毛几乎一无所知。然而,IV 型菌毛蛋白基因存在于梭菌属所有成员的基因组中,并且所有艰难梭菌菌株都编码完整的 T4P 生物发生机制组件集和可变数量的 IV 型菌毛蛋白。我们假设艰难梭菌 IV 型菌毛通过与革兰氏阴性 IV 型菌毛不同的结构特征,直接介导人类细胞粘附,这对于定植和毒力都很重要。因此,我们试图通过追求以下具体目标来定义艰难梭菌 IV 型菌毛蛋白结构,包括单个蛋白质成分和组装的超分子附属物,并鉴定其人类宿主细胞受体:(1)确定单个艰难梭菌 IV 型菌毛蛋白的原子结构; (2) 定义艰难梭菌 Tye IV 菌毛的组成和结构; (3) 鉴定与艰难梭菌 IV 型菌毛特异性结合的宿主分子。我们提出的研究艰难梭菌 IV 型菌毛结构和功能的综合方法将利用各种分辨率的蛋白质结构测定方法,包括 X 射线晶体学、核磁共振波谱、小角 X 射线散射和冷冻电子显微镜,以及最先进的基于质谱的方法来定义多组分蛋白质组装体的组成,图 蛋白质-蛋白质界面并识别新的受体分子。为了确保我们提出的研究取得成功,我们组建了一支由优秀研究人员组成的团队,他们在这些实验技术、艰难梭菌生物学和 IV 型菌毛结构和功能方面拥有丰富的专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC JOHN SUNDBERG其他文献
ERIC JOHN SUNDBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC JOHN SUNDBERG', 18)}}的其他基金
Gatekeeping glycan metabolism in the human gut microbiome
人类肠道微生物组中的聚糖代谢把关
- 批准号:
10737225 - 财政年份:2023
- 资助金额:
$ 54.67万 - 项目类别:
Engineering mono-fucosylated IgGs to fine-tune antibody-mediated effector functions
工程化单岩藻糖基化 IgG 来微调抗体介导的效应功能
- 批准号:
10647938 - 财政年份:2023
- 资助金额:
$ 54.67万 - 项目类别:
Engineering antibody effector functions by Glycan Remodeling Yeast Display
通过聚糖重塑酵母展示工程化抗体效应子功能
- 批准号:
10494252 - 财政年份:2021
- 资助金额:
$ 54.67万 - 项目类别:
Engineering antibody effector functions by Glycan Remodeling Yeast Display
通过聚糖重塑酵母展示工程化抗体效应子功能
- 批准号:
10373251 - 财政年份:2021
- 资助金额:
$ 54.67万 - 项目类别:
Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
- 批准号:
10377400 - 财政年份:2020
- 资助金额:
$ 54.67万 - 项目类别:
Structure & Function of Clostridium difficile Type IV Pili
结构
- 批准号:
10087197 - 财政年份:2020
- 资助金额:
$ 54.67万 - 项目类别:
Towards one-step enzymatic defucosylation of antibodies
抗体的一步酶促去岩藻糖基化
- 批准号:
10176408 - 财政年份:2020
- 资助金额:
$ 54.67万 - 项目类别:
Towards one-step enzymatic defucosylation of antibodies
抗体的一步酶促去岩藻糖基化
- 批准号:
10041315 - 财政年份:2020
- 资助金额:
$ 54.67万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 54.67万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 54.67万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 54.67万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 54.67万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 54.67万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 54.67万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 54.67万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 54.67万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 54.67万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 54.67万 - 项目类别:














{{item.name}}会员




